Biotech 2025: AI-Driven Models to Revolutionize Drug Discovery
Andrea highlights the potential of Large Quantitative Models (LQMs) in tackling undruggable conditions like Alzheimer’s. She emphasizes the need for collaboration and infrastructure investment. By 2025, LQMs will redefine healthcare, reducing R&D timelines and costs. Andrea says, “The synergy between computational chemistry and AI is at an inflection point,” enabling breakthroughs in medicine.